Fallbericht
Salvage Therapy with Gilteritinib Plus Venetoclax for FLT3-ITD-Positive AML: A Case Report and Literature Review
Diseases and Research · 2022
DOI: 10.54457/dr.202201002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diseases and Research, 2022. Verfasst von Dian Lou und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lou, D., Liu, L., & Qin, W. (2022). Salvage Therapy with Gilteritinib Plus Venetoclax for FLT3-ITD-Positive AML: A Case Report and Literature Review. Diseases and Research. https://doi.org/10.54457/dr.202201002
Vancouver
Lou D, Liu L, Qin W. Salvage Therapy with Gilteritinib Plus Venetoclax for FLT3-ITD-Positive AML: A Case Report and Literature Review. Diseases and Research. 2022. doi:10.54457/dr.202201002
BibTeX
@article{Lou2022,
author = {Lou, Dian and Liu, Li and Qin, Weiwei},
title = {Salvage Therapy with Gilteritinib Plus Venetoclax for FLT3-ITD-Positive AML: A Case Report and Literature Review},
journal = {Diseases and Research},
year = {2022},
doi = {10.54457/dr.202201002}
}
EUVIMED